0001607854-19-000001.txt : 20191107 0001607854-19-000001.hdr.sgml : 20191107 20191107172603 ACCESSION NUMBER: 0001607854-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191107 DATE AS OF CHANGE: 20191107 EFFECTIVENESS DATE: 20191107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lysosomal Therapeutics, Inc. CENTRAL INDEX KEY: 0001607854 IRS NUMBER: 454015802 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352903 FILM NUMBER: 191201413 BUSINESS ADDRESS: STREET 1: 19 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-9620 MAIL ADDRESS: STREET 1: 19 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001607854 Lysosomal Therapeutics, Inc. 19 BLACKSTONE STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-714-9620 DELAWARE None None Corporation true Cornelis Been c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Robert Carpenter c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Daniel Geffken c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Bruce L. Booth c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Steven E. Hall c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Carole Nuechterlein c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Clay Thorp c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2019-10-25 false true true false 0 3000000 1000000 2000000 false 10 0 0 0 false Lysosomal Therapeutics, Inc. /s/ Cornelis Been Cornelis Been President & CEO 2019-11-07